Patents Assigned to CRYSTAL BIOPHARMACEUTICAL LLC
  • HDAC inhibiting derivatives of camptothecin
    Patent number: 8980909
    Abstract: The disclosure includes hydroxamic compounds of Formula I: (Formula I) wherein Z, L, R1, R2, and R3 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: March 17, 2015
    Assignee: Crystal Biopharmaceutical LLC
    Inventors: Yi Chen, Yu Chen
  • HDAC INHIBITING DERIVATIVES OF CAMPTOTHECIN
    Publication number: 20130281402
    Abstract: The disclosure includes hydroxamic compounds of Formula I: (Formula I) wherein Z, L, R1, R2, and R3 are defined herein. Also disclosed is a method for treating a neoplastic disease or an immune disease with these compounds.
    Type: Application
    Filed: January 6, 2012
    Publication date: October 24, 2013
    Applicant: CRYSTAL BIOPHARMACEUTICAL LLC
    Inventors: Yi Chen, Yu Chen